Stalevo
These highlights do not include all the information needed to use STALEVO safely and effectively. See full prescribing information for STALEVO. STALEVO (carbidopa, levodopa and entacapone) tablets, for oral useInitial U.S. Approval: 2003
53c488d8-4146-7563-8021-d90c931d1a95
HUMAN PRESCRIPTION DRUG LABEL
Jul 30, 2021
Almatica Pharma LLC
DUNS: 962454505
Products 6
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
carbidopa, levodopa, and entacapone
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (14)
carbidopa, levodopa, and entacapone
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (15)
carbidopa, levodopa, and entacapone
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (15)
carbidopa, levodopa, and entacapone
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (15)
carbidopa, levodopa, and entacapone
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (14)
carbidopa, levodopa, and entacapone
Product Details
FDA regulatory identification and product classification information